Vincerx Pharma (VINC)
(Real Time Quote from BATS)
$0.71 USD
+0.12 (20.34%)
Updated Jun 27, 2024 03:06 PM ET
2-Buy of 5 2
F Value A Growth D Momentum D VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 35% (88 out of 250)Zacks Sector Rank
Top 44% (7 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.35 | 9.99 |
Current Quarter Estimate | -0.17 | 7.43 | 57.00 |
Year Ago Quarter Estimate | -0.52 | 0.12 | 52.54 |
Next Quarter Estimate | -0.14 | 7.81 | 61.00 |
Next Year Estimate | -0.48 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 60.85 | 15.50 | 15.67 |
Next Year | 35.14 | 9.60 | 9.31 |
Last 5 Years | NA | 3.70 | 8.10 |
Next 5 Years | NA | 20.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | NA | 1.99 |
Price/Cash Flow (MRFY) | NA | 15.40 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -183.66% |
Return on Equity (TTM) | -261.83% | -59.96% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.